Refine by
Biopsy Suppliers In Usa New York
10 companies found
based inChicago, ILLINOIS (USA)
In 2007, our engineers using radar technology and machine learning to help the U.S. Army catch bad guys figured out how to use that same technology to catch bad cancer cells. We have been hard at work for over 12 years experimenting, improving ...
Cancer diagnosis with ultrasound requires great vision. Koios uses artificial intelligence and machine learning to provide clinical decision support (“DS”) for physicians and technologists when using ultrasound to detect and diagnose ...
based inLondon, UNITED KINGDOM
Hemogenyx Pharmaceuticals is developing breakthrough therapies for the treatment of blood diseases. Hemogenyx Pharmaceuticals plc is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx ...
Hemogenyx Pharmaceuticals utilizes postnatal human hemogenic endothelial cells (Hu-PHEC cells), discovered by Hemogenyx Pharmaceuticals’ Co-Founder Dr Vladislav Sandler, to generate cancer-free hematopoietic stem cells (HSC) for use in ...
based inRochester, NEW YORK (USA)
Electro Surgical Instrument Company has been manufacturing lighted retractors and other lighted surgical instruments for over 115 years. We offer instrument repair and parts replacement for our current product line and, where practical, manufacture ...
Baby Tischler Biopsy Punch Forceps 8″ (20.3cm) shaft, 2 x 4mm bite with thumb ...
based inHauppauge, NEW YORK (USA)
Busse Hospital Disposables has a proven track record for over 50 years of providing the health care industry with high-quality products and services: All our products are manufactured with strict adherence to industry standards and guidelines. Our ...
Ultra-sharp and manufactured to the highest tolerances, the Busse Bone Marrow Biopsy Needle is designed to provide outstanding and consistent performance. With its substantial, easily gripped handle, our 11g x 4″ ...
based inNew York, NEW YORK (USA)
miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of disease. The Company has developed the miR Disease Management ...
The initial test delivered by the miR Disease Management Platform® is the miR Sentinel™ Prostate Cancer Test, the first and only standalone, non-invasive liquid biopsy urine test that accurately detects, classifies and can ...
based inSuffern, NEW YORK (USA)
An advanced diagnostic platform that leverages artificial intelligence (AI) enabled tissue analysis and 3D imaging to reliably detect precancerous cells. CDx provides an integrated solution of enhanced tissue sampling and an AI-assisted diagnostic ...
AI-powered diagnostic platform to help prevent esophageal cancer. Included in the Standard of Practice Guidelines for the screening and surveillance of Barrett’s esophagus, WATS3D is our proprietary diagnostic platform for identifying ...
based inLatham, NEW YORK (USA)
AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine. These devices provide ...
The BioSentry tract sealant system is the first biopsy sealant system of its kind designed specifically to address the issues of biopsy-related pneumothorax. The BioSentry tract sealant system deploys a ...
based inSyracuse, NEW YORK (USA)
Mesothelioma is an aggressive cancer that affects the lining of the lungs, heart, or abdomen. Caused by the inhalation of asbestos fibers, mesothelioma is often diagnosed in older individuals who worked with asbestos products. Prognosis for ...
based inParis Cedex 06, FRANCE
We develop and commercialize patented, disruptive liquid biopsy tests – innovative blood tests in oncology – based on a unique cell isolation technology called ISET (Isolation by SizE of Tumor cells) and cyto-molecular profiling of Circulating Tumor ...
Cancer is the second cause of death, accounting for nearly 9 million deaths in 2017 all over the world. In 2019, 1,762,450 new cancer cases and 606,880 cancer deaths are projected to occur in the United States. It is estimated that metastasis is the ...
based inNew York City, NEW YORK (USA)
Led by a team of experts in the fields of life sciences, oncology, pathology, technology, machine learning, and healthcare, Paige strives to transform cancer diagnostics. We make it possible not only to provide additional information from digital ...
The Paige Prostate Suite is comprised of Paige Prostate Detect, Paige Prostate Grade & Quantify, and Paige Prostate Perineural Invasion. The AI applications available in the Paige Prostate Suite aim to assist in efficiencies of reads and reduce ...